Publications by authors named "Randall F Howard"

Claim this Profile
I
Immunofocusing humoral immunity potentiates the functional efficacy of the AnAPN1 malaria transmission-blocking vaccine antigen.
Nicole G Bender, Prachi Khare, Juan Martinez, Rebecca E Tweedell, Vincent O Nyasembe, Randall F Howard

NPJ Vaccines· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria.
Benjamin Mordmüller, Mihály Sulyok, Diane Egger-Adam, Mafalda Resende, Willem A de Jongh, Randall F Howard

Clin Infect Dis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a sandwich ELISA to detect Leishmania 40S ribosomal protein S12 antigen from blood samples of visceral leishmaniasis patients.
Wen-Wei Zhang, Ayan Kumar Ghosh, Raodoh Mohamath, Jacqueline Whittle, Alessandro Picone, Randall F Howard

BMC Infect Dis· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR-adjuvanted nanoparticle vaccines differentially influence the quality and longevity of responses to malaria antigen Pfs25.
Elizabeth A Thompson, Sebastian Ols, Kazutoyo Miura, Kelly Rausch, David L Narum, Randall F Howard

JCI Insight· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment.
Faria Hossain, Prakash Ghosh, Md Anik Ashfaq Khan, Malcolm S Duthie, Aarthy C Vallur, Randall F Howard

PLoS One· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A defined subunit vaccine that protects against vector-borne visceral leishmaniasis.
Malcolm S Duthie, Lais Pereira, Michelle Favila, Kimberly A Hofmeyer, S Jim Reed, Randall F Howard

NPJ Vaccines· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines.
Diego A Espinosa, Joel Vega-Rodriguez, Yevel Flores-Garcia, Amy R Noe, Christian Muñoz, Randall F Howard

Infect Immun· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semi-quantitative measurement of asymptomatic L. infantum infection and symptomatic visceral leishmaniasis in dogs using Dual-Path Platform® CVL.
Mandy Larson, Angela Toepp, Benjamin Scott, , Melissa Kurtz, Randall F Howard

Appl Microbiol Biotechnol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant and carrier protein-dependent T-cell priming promotes a robust antibody response against the Plasmodium falciparum Pfs25 vaccine candidate.
Andrea J Radtke, Charles F Anderson, Nicolas Riteau, Kelly Rausch, Puthupparampil Scaria, Randall F Howard

Sci Rep· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.
Robert G Schaut, Tara L Grinnage-Pulley, Kevin J Esch, Angela J Toepp, Malcolm S Duthie, Randall F Howard

Vaccine· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis.
Malcolm S Duthie, Michelle Favila, Kimberley A Hofmeyer, Yeung L Tutterrow, Steven J Reed, Randall F Howard

Vaccine· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigen.
Susan L Baldwin, Will Roeffen, Susheel K Singh, Regis W Tiendrebeogo, Michael Christiansen, Randall F Howard

Vaccine· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion Domains.
Raul Herrera, Charles Anderson, Krishan Kumar, Alvaro Molina-Cruz, Vu Nguyen, Randall F Howard

Infect Immun· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic accuracy of rK28-based immunochromatographic rapid diagnostic tests for visceral leishmaniasis: a prospective clinical cohort study in Sudan.
Maowia Mukhtar, Asim Abdoun, Abdallah E Ahmed, Hashim Ghalib, Steven G Reed, Randall F Howard

Trans R Soc Trop Med Hyg· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of point-of-care tests for the rapid diagnosis of visceral leishmaniasis in East African patients.
Asrat Bezuneh, Maowia Mukhtar, Asim Abdoun, Tedla Teferi, Yegnasew Takele, Randall F Howard

Am J Trop Med Hyg· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi.
Regis Gomes, Clarissa Teixeira, Fabiano Oliveira, Phillip G Lawyer, Dia-Eldin Elnaiem, Randall F Howard

PLoS Negl Trop Dis· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intradermally administered TLR4 agonist GLA-SE enhances the capacity of human skin DCs to activate T cells and promotes emigration of Langerhans cells.
Laura P Schneider, Antoinet J Schoonderwoerd, Magdalini Moutaftsi, Randall F Howard, Steven G Reed

Vaccine· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice.
Joanne M Lumsden, Saule Nurmukhambetova, Jennifer H Klein, Jetsumon Sattabongkot, Jason W Bennett, Randall F Howard

Vaccine· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the safety and immunogenicity in rhesus monkeys of a recombinant malaria vaccine for Plasmodium vivax with a synthetic Toll-like receptor 4 agonist formulated in an emulsion.
Joanne M Lumsden, Sathit Pichyangkul, Utaiwan Srichairatanakul, Kosol Yongvanitchit, Amporn Limsalakpetch, Randall F Howard

Infect Immun· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis.
Yasuyuki Goto, Ajay Bhatia, Vanitha S Raman, Hong Liang, Raodoh Mohamath, Randall F Howard

Clin Vaccine Immunol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2--a GLURP-MSP3 fusion protein malaria vaccine candidate.
Susana Lousada-Dietrich, Prajakta S Jogdand, Søren Jepsen, Vera V Pinto, Sisse B Ditlev, Randall F Howard

Vaccine· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE.
Joelma Trigo, Melissa Abbehusen, Eduardo M Netto, Maria Nakatani, Geraldo Pedral-Sampaio, Randall F Howard

Vaccine· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimized subunit vaccine protects against experimental leishmaniasis.
Sylvie Bertholet, Yasuyuki Goto, Lauren Carter, Ajay Bhatia, Randall F Howard

Vaccine· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infection.
Yasuyuki Goto, Ajay Bhatia, Vanitha S Raman, Silvia E Z Vidal, Sylvie Bertholet, Randall F Howard

Vaccine· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs.
Yasuyuki Goto, Randall F Howard, Ajay Bhatia, Joelma Trigo, Maria Nakatani

Vet Parasitol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis